-S Higashiyama Researcher Activity Profile

Research Author Detailed Information 

S Higashiyama Publication Rate By Year

S Higashiyama has published 2 paper(s) in 1996, 3 paper(s) in 1997, 1 paper(s) in 1998, 1 paper(s) in 1999, 1 paper(s) in 2000, 1 paper(s) in 2001, for a total of 9 research publications in total.

S S Higashiyama Author Information

LAST NAME: higashiyama

FIRST NAME: s

INITIALS: S

AFFILIATION:

Papers

S Higashiyama's Publication Record

1. NTAKalpha and beta isoforms stimulate breast tumor cell growth by means of different receptor combinations. Year Published: 2000
Department of Biochemistry, Room B-Osaka University Medical School, Yamadaoka, Suita, Osaka 565-0871, Japan.
2. Osmotic stress induces HB-EGF gene expression via Ca(2+)/Pyk2/JNK signal cascades in rat aortic smooth muscle cells. Year Published: 2001
Department of Biochemistry, Osaka University Medical School, Yamadaoka, Suita, Osaka 565-0871, Japan.
3. Fragmentation of ceruloplasmin following non-enzymatic glycation reaction. Year Published: 1997
Department of Biochemistry, Osaka University Medical School.
4. A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4. Year Published: 1998
Department of Biochemistry, Osaka University Medical School, Suita. shigeki@biochem.med.osaka-u.ac.jp
5. CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain. Year Published: 1997
Department of Biochemistry, Osaka University Medical School, Suita.
6. Purification and characterization of a novel vascular endothelial cell growth inhibitor secreted by macrophage-like U-937 cells. Year Published: 1999
Department of Biochemistry, Osaka University Medical School, Yamadaoka,Suita, Osaka, Japan.
7. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Year Published: 1996
Department of Biochemistry, Osaka University Medical School, Japan.
8. [Effects of a reduction or deviation of metastasis inhibitory factor MRP-1/CD9 on postoperative follow-up results in patients with lung cancer] Year Published: 1996
9. [KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis] Year Published: 1997